Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Morandi

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Science Translational Medicine|February 28, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancerMarina Bacci, Nicla Lorito, Alfredo Smiriglia, et al.
Cancer Treatment Reviews|June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysisCarlotta Becherini, Luca Visani, Saverio Caini, et al.
Nature Communications|July 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancersRania El-Botty, Ludivine Morriset, Elodie Montaudon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 20, 2023
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)Orit Kaidar-Person, Icro Meattini, Liesbeth J Boersma, et al.
Nature Genetics|August 10, 2018
Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancerJingjing Chen, Ilaria Guccini, Diletta Di Mitri, et al.
Nature Genetics|January 17, 2018
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancerJingjing Chen, Ilaria Guccini, Diletta Di Mitri, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Science Translational Medicine|February 28, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancerMarina Bacci, Nicla Lorito, Alfredo Smiriglia, et al.
Cancer Treatment Reviews|June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysisCarlotta Becherini, Luca Visani, Saverio Caini, et al.
Nature Communications|July 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancersRania El-Botty, Ludivine Morriset, Elodie Montaudon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 20, 2023
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)Orit Kaidar-Person, Icro Meattini, Liesbeth J Boersma, et al.
Nature Genetics|August 10, 2018
Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancerJingjing Chen, Ilaria Guccini, Diletta Di Mitri, et al.
Nature Genetics|January 17, 2018
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancerJingjing Chen, Ilaria Guccini, Diletta Di Mitri, et al.
Pageof 7